Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
BRKR
Bruker Corporation
Advanced imaging platforms include medical imaging-grade instruments suitable for research and preclinical imaging.
|
$6.93B |
$45.67
+1.21%
|
|
STVN
Stevanato Group S.p.A.
Directly manufactures Prefillable Syringes used for sterile biologic and small-molecule injections.
|
$6.45B |
$21.28
+2.21%
|
|
GKOS
Glaukos Corporation
Glaukos directly manufactures ophthalmology devices, including iStent MIGS implants used in eye surgeries.
|
$6.41B |
$111.70
+2.59%
|
|
BTSG
BrightSpring Health Services, Inc. Common Stock
Company operates home health and hospice services to patients in home and community settings.
|
$6.37B |
$35.90
-1.75%
|
|
CHE
Chemed Corporation
Chemed's VITAS Hospice provides direct home health and hospice care services.
|
$6.27B |
$430.00
-0.02%
|
|
GRFS
Grifols, S.A.
Grifols operates as a large, global pharmaceutical company with a core focus on plasma-derived therapies.
|
$6.21B |
$9.04
-1.04%
|
|
KYMR
Kymera Therapeutics, Inc.
Kymera's core offering is oral small molecule therapeutics designed to degrade disease-causing proteins (STAT6, IRAK4, IRF5) in immunology indications.
|
$6.13B |
$85.58
-4.57%
|
|
PTCT
PTC Therapeutics, Inc.
Sephience PKU and other PTC therapies are oral small-molecule drugs, a major product category for the company.
|
$6.06B |
$76.29
+0.86%
|
|
BLCO
Bausch + Lomb Corporation
Ophthalmology Devices – direct manufacture and sale of eye-care surgical devices and related ophthalmic equipment.
|
$6.05B |
$17.07
+0.44%
|
|
PTGX
Protagonist Therapeutics, Inc.
Direct product category: PTGX's core business is peptide therapeutics.
|
$5.90B |
$94.82
-0.56%
|
|
PRAX
Praxis Precision Medicines, Inc.
Praxis's Cerebrum platform develops oral small-molecule CNS therapies (e.g., ulixacaltamide, Vormatrigine).
|
$5.82B |
$277.20
+3.12%
|
|
PCVX
Vaxcyte, Inc.
PCVX directly develops and is advancing vaccine products (VAX-24, VAX-31) including pneumococcal conjugate vaccines, making Vaccines the core investable product category.
|
$5.76B |
$44.36
-0.31%
|
|
MIR
Mirion Technologies, Inc.
Core business: Mirion designs and manufactures medical devices and biometric sensing equipment used in radiology, radiation therapy, and nuclear medicine.
|
$5.69B |
$24.32
-1.40%
|
|
LTH
Life Time Group Holdings, Inc.
MIORA longevity clinics and other healthcare services are provided as part of the ecosystem.
|
$5.68B |
$25.82
+0.16%
|
|
OLED
Universal Display Corporation
Contract research services via Adesis subsidiary.
|
$5.67B |
$119.27
+0.92%
|
|
COGT
Cogent Biosciences, Inc.
Cogent's lead asset bezuclastinib and the described pipeline assets are primarily oral small-molecule tyrosine kinase inhibitors, i.e., Oral Small Molecule Therapeutics.
|
$5.62B |
$40.21
-4.51%
|
|
TFX
Teleflex Incorporated
Teleflex is a global medical device company designing, manufacturing, and selling single-use medical devices across critical care, surgical, and interventional markets.
|
$5.60B |
$126.51
-0.29%
|
|
RDNT
RadNet, Inc.
RadNet operates outpatient imaging centers/ASC, providing diagnostic imaging services.
|
$5.58B |
$72.54
-1.89%
|
|
CDTX
Cidara Therapeutics, Inc.
CD388 is an antiviral small-molecule therapeutic targeting neuraminidase for universal influenza prevention and treatment.
|
$5.58B |
$220.02
-0.29%
|
|
VNT
Vontier Corporation
Repair Solutions includes diagnostic equipment launches for vehicle repair workflows.
|
$5.47B |
$37.30
+0.53%
|
|
OPCH
Option Care Health, Inc.
OPCH delivers home health infusion and hospice-related services in patients' homes, aligning with home health care offerings.
|
$5.44B |
$33.55
+0.92%
|
|
IRTC
iRhythm Technologies, Inc.
Direct product: iRhythm's patch-based patient monitoring device and associated software for continuous cardiac monitoring.
|
$5.43B |
$169.07
+0.14%
|
|
ESE
ESCO Technologies Inc.
Diagnostic Equipment reflects ESCO's diagnostic testing instruments and related software for measurement and monitoring.
|
$5.33B |
$206.33
+1.06%
|
|
UNMA
Unum Group 6.250% JR NT58
Disability insurance is a core component of Unum's financial protection offerings in workplace benefits.
|
$5.23B |
$23.09
-0.17%
|
|
GNTX
Gentex Corporation
Medical Devices & Biometrics covers EyeLock iris biometrics and eSight medical device initiatives tied to Gentex's diversification.
|
$5.19B |
$23.65
-0.08%
|
|
MMSI
Merit Medical Systems, Inc.
Directly tied to Merit's core cardiology/interventional devices, including cardiac intervention products and lead-management solutions (Cook acquisition).
|
$5.12B |
$86.39
-0.36%
|
|
CRSP
CRISPR Therapeutics AG
CRISPR-based ex vivo gene-editing therapy CASGEVY is a gene therapy product.
|
$5.12B |
$56.24
-0.77%
|
|
TGTX
TG Therapeutics, Inc.
BRIUMVI is TG Therapeutics' flagship monoclonal antibody therapeutic (anti-CD20) for relapsing MS, the core product driving revenue and growth.
|
$4.98B |
$31.42
+0.22%
|
|
GHC
Graham Holdings Company
Healthcare Services & Facilities reflecting CSI Pharmacy and patient services.
|
$4.86B |
$1113.53
-0.39%
|
|
INDV
Indivior PLC
SUBLOCADE's extended-release delivery represents a drug delivery platform (monthly dosing), a core investable theme.
|
$4.86B |
$35.23
-0.93%
|
|
SHC
Sotera Health Company
Nelson Labs provides outsourced microbiological and analytical chemistry testing plus regulatory advisory services.
|
$4.77B |
$16.81
-0.12%
|
|
ADMA
ADMA Biologics, Inc.
ADMA's core offerings are plasma-derived immunology therapeutics (immunoglobulins) used to treat immune deficiencies and related conditions.
|
$4.71B |
$19.73
-0.23%
|
|
ALKS
Alkermes plc
Direct product category encompassing Alkermes' oral small-molecule therapeutics, including LYBALVI.
|
$4.65B |
$28.19
-1.09%
|
|
CRNX
Crinetics Pharmaceuticals, Inc.
Crinetics' NDC platform and drug-conjugate strategy reflect a drug-delivery platform providing targeted payload delivery.
|
$4.64B |
$49.31
-2.34%
|
Showing page 7 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
